Chinese General Practice ›› 2025, Vol. 28 ›› Issue (22): 2769-2775.DOI: 10.12114/j.issn.1007-9572.2024.0401
Special Issue: 家庭医生签约最新文章合辑
• Original Research • Previous Articles
Received:
2024-09-10
Revised:
2024-10-15
Published:
2025-08-05
Online:
2025-06-30
Contact:
GUO Zhinan
通讯作者:
郭志南
作者简介:
作者贡献:
陈友兰、郭志南负责文章的构思与设计;陈友兰、蓝彦琦进行文章的可行性分析;吴阿华、张海霞、黄健康负责文献检索、数据收集和整理;陈友兰负责论文撰写,进行结果的分析与解释,对文章整体负责;郭志南负责文章的质量控制、审校修订、监督管理。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0401
年龄 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||
---|---|---|---|---|---|---|
男 | 女 | 合计 | 男 | 女 | 合计 | |
65~69岁 | 2 610(17.22) | 3 448(22.75) | 6 058(39.98) | 1 320(14.94) | 1 770(20.03) | 3 090(34.96) |
70~74岁 | 1 787(11.79) | 2 541(16.77) | 4 328(28.56) | 1 192(13.49) | 1 347(13.47) | 2 539(28.73) |
75~79岁 | 1 131(7.46) | 1 557(10.27) | 2 688(17.74) | 808(9.14) | 843(9.54) | 1 651(18.68) |
80~84岁 | 584(3.85) | 780(5.15) | 1 364(9.00) | 442(5.00) | 496(5.61) | 938(10.61) |
85~89岁 | 236(1.56) | 349(2.30) | 585(3.86) | 192(2.17) | 272(3.08) | 464(5.25) |
≥90岁 | 48(0.32) | 83(0.55) | 131(0.86) | 65(0.74) | 91(1.03) | 156(1.77) |
合计 | 6 396(42.21) | 8 758(57.79) | 15 154(100.00) | 4 019(45.47) | 4 819(54.53) | 8 838(100.00) |
Table 1 The gender and age distribution of hypertensive patients aged 65 and above between the signed and unsigned groups
年龄 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||
---|---|---|---|---|---|---|
男 | 女 | 合计 | 男 | 女 | 合计 | |
65~69岁 | 2 610(17.22) | 3 448(22.75) | 6 058(39.98) | 1 320(14.94) | 1 770(20.03) | 3 090(34.96) |
70~74岁 | 1 787(11.79) | 2 541(16.77) | 4 328(28.56) | 1 192(13.49) | 1 347(13.47) | 2 539(28.73) |
75~79岁 | 1 131(7.46) | 1 557(10.27) | 2 688(17.74) | 808(9.14) | 843(9.54) | 1 651(18.68) |
80~84岁 | 584(3.85) | 780(5.15) | 1 364(9.00) | 442(5.00) | 496(5.61) | 938(10.61) |
85~89岁 | 236(1.56) | 349(2.30) | 585(3.86) | 192(2.17) | 272(3.08) | 464(5.25) |
≥90岁 | 48(0.32) | 83(0.55) | 131(0.86) | 65(0.74) | 91(1.03) | 156(1.77) |
合计 | 6 396(42.21) | 8 758(57.79) | 15 154(100.00) | 4 019(45.47) | 4 819(54.53) | 8 838(100.00) |
组别 | 例数 | 2021年 | 2023年 | χ2值 | P值 |
---|---|---|---|---|---|
签约组 | 15 154 | 9 108(60.10) | 11 635(76.78) | 6.697 | 0.010 |
未签约组 | 8 838 | 5 501(62.24) | 6 064(68.61) | 1.084 | 0.298 |
χ2值 | 0.084 | 1.624 | |||
P值 | 0.772 | 0.203 |
Table 2 Blood pressure control status of signed and unsigned groups
组别 | 例数 | 2021年 | 2023年 | χ2值 | P值 |
---|---|---|---|---|---|
签约组 | 15 154 | 9 108(60.10) | 11 635(76.78) | 6.697 | 0.010 |
未签约组 | 8 838 | 5 501(62.24) | 6 064(68.61) | 1.084 | 0.298 |
χ2值 | 0.084 | 1.624 | |||
P值 | 0.772 | 0.203 |
组别 | 例数 | 左侧舒张压 | 左侧收缩压 | 右侧舒张压 | 右侧收缩压 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | ||
签约组 | 15 154 | 80±10 | 78±8a | 1(-5,7) | 134±18 | 136±16a | 0(-2,6) | 81±10 | 79±9a | 0(-1,2) | 138±15 | 132±20a | 0(-1,7) |
未签约组 | 8 838 | 81±10 | 79±9a | 0(-5,5) | 138±16 | 139±18a | 1(-6,9) | 82±10 | 80±9a | 0(-5,6) | 138±16 | 137±16a | -1(-9,9) |
u值 | — | — | -4.254 | — | — | -1.684 | — | — | -0.866 | — | — | -17.168 | |
P值 | — | — | <0.001 | — | — | 0.092 | — | — | 0.387 | — | — | <0.001 |
Table 3 Blood pressure measurement of signed and unsigned groups
组别 | 例数 | 左侧舒张压 | 左侧收缩压 | 右侧舒张压 | 右侧收缩压 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | ||
签约组 | 15 154 | 80±10 | 78±8a | 1(-5,7) | 134±18 | 136±16a | 0(-2,6) | 81±10 | 79±9a | 0(-1,2) | 138±15 | 132±20a | 0(-1,7) |
未签约组 | 8 838 | 81±10 | 79±9a | 0(-5,5) | 138±16 | 139±18a | 1(-6,9) | 82±10 | 80±9a | 0(-5,6) | 138±16 | 137±16a | -1(-9,9) |
u值 | — | — | -4.254 | — | — | -1.684 | — | — | -0.866 | — | — | -17.168 | |
P值 | — | — | <0.001 | — | — | 0.092 | — | — | 0.387 | — | — | <0.001 |
项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
---|---|---|---|---|---|---|---|---|
2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
BMI | 4.537 | 0.033 | 0.080 | 0.777 | ||||
<18.5 kg/m2 | 309(2.04) | 333(2.20) | 226(2.56) | 263(2.98) | ||||
18.5~<24.0 kg/m2 | 7 110(46.92) | 9 343(61.65) | 4 161(47.08) | 4 293(48.57) | ||||
24.0~<28.0 kg/m2 | 5 729(37.81) | 4 057(26.77) | 3 422(38.72) | 3 450(39.04) | ||||
≥28.0 kg/m2 | 2 006(13.24) | 1 421(9.38) | 1 029(11.64) | 832(9.41) | ||||
中心性肥胖 | 11 565(76.32) | 9 598(63.34) | 3.986 | 0.046 | 6 772(76.62) | 6 754(76.42)a | 0.028 | 0.868 |
空腹血糖偏高 | 5 618(37.07) | 1 918(12.66) | 15.360 | <0.001 | 3 076(34.80) | 1 883(21.31) | 4.861 | 0.027 |
糖尿病患者空腹血糖偏高 | 2 749(54.96) | 1 395(27.89) | 15.014 | <0.001 | 1 166(52.22) | 872(39.05) | 3.408 | 0.055 |
非糖尿病患者空腹血糖偏高 | 2 869(28.26) | 523(5.15) | 19.198 | <0.001 | 1 910(28.92) | 1 011(15.31) | 5.711 | 0.017 |
血脂异常 | 11 541(76.16) | 11 257(74.28) | 0.107 | 0.744 | 6 669(75.46) | 6 789(76.82) | 0.110 | 0.741 |
肝功能异常 | 2 756(18.19) | 2 698(17.80) | 0.001 | 0.999 | 1 635(18.50) | 1 465(16.58) | 0.112 | 0.738 |
肾功能异常 | 6 734(44.44) | 6 234(41.16) | 0.184 | 0.668 | 4 010(45.37) | 3 484(39.42) | 0.739 | 0.390 |
血常规异常 | 2 076(13.70) | 1 691(11.16) | 0.411 | 0.521 | 1 189(13.45) | 1 037(11.73) | 0.046 | 0.831 |
尿常规异常 | 6 693(44.17) | 5 686(37.52) | 0.744 | 0.388 | 3 594(40.67) | 3 189(36.08) | 0.528 | 0.467 |
心电图检查异常 | 8 525(56.26) | 4 957(32.71) | 10.710 | 0.001 | 5 087(56.98) | 4 437(50.20)a | 0.985 | 0.321 |
B超检查异常 | 9 148(60.37) | 8 287(54.69) | 0.512 | 0.474 | 5 387(60.95) | 4 785(54.14) | 1.003 | 0.317 |
Table 4 Health examination results of signed and unsigned groups
项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
---|---|---|---|---|---|---|---|---|
2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
BMI | 4.537 | 0.033 | 0.080 | 0.777 | ||||
<18.5 kg/m2 | 309(2.04) | 333(2.20) | 226(2.56) | 263(2.98) | ||||
18.5~<24.0 kg/m2 | 7 110(46.92) | 9 343(61.65) | 4 161(47.08) | 4 293(48.57) | ||||
24.0~<28.0 kg/m2 | 5 729(37.81) | 4 057(26.77) | 3 422(38.72) | 3 450(39.04) | ||||
≥28.0 kg/m2 | 2 006(13.24) | 1 421(9.38) | 1 029(11.64) | 832(9.41) | ||||
中心性肥胖 | 11 565(76.32) | 9 598(63.34) | 3.986 | 0.046 | 6 772(76.62) | 6 754(76.42)a | 0.028 | 0.868 |
空腹血糖偏高 | 5 618(37.07) | 1 918(12.66) | 15.360 | <0.001 | 3 076(34.80) | 1 883(21.31) | 4.861 | 0.027 |
糖尿病患者空腹血糖偏高 | 2 749(54.96) | 1 395(27.89) | 15.014 | <0.001 | 1 166(52.22) | 872(39.05) | 3.408 | 0.055 |
非糖尿病患者空腹血糖偏高 | 2 869(28.26) | 523(5.15) | 19.198 | <0.001 | 1 910(28.92) | 1 011(15.31) | 5.711 | 0.017 |
血脂异常 | 11 541(76.16) | 11 257(74.28) | 0.107 | 0.744 | 6 669(75.46) | 6 789(76.82) | 0.110 | 0.741 |
肝功能异常 | 2 756(18.19) | 2 698(17.80) | 0.001 | 0.999 | 1 635(18.50) | 1 465(16.58) | 0.112 | 0.738 |
肾功能异常 | 6 734(44.44) | 6 234(41.16) | 0.184 | 0.668 | 4 010(45.37) | 3 484(39.42) | 0.739 | 0.390 |
血常规异常 | 2 076(13.70) | 1 691(11.16) | 0.411 | 0.521 | 1 189(13.45) | 1 037(11.73) | 0.046 | 0.831 |
尿常规异常 | 6 693(44.17) | 5 686(37.52) | 0.744 | 0.388 | 3 594(40.67) | 3 189(36.08) | 0.528 | 0.467 |
心电图检查异常 | 8 525(56.26) | 4 957(32.71) | 10.710 | 0.001 | 5 087(56.98) | 4 437(50.20)a | 0.985 | 0.321 |
B超检查异常 | 9 148(60.37) | 8 287(54.69) | 0.512 | 0.474 | 5 387(60.95) | 4 785(54.14) | 1.003 | 0.317 |
项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
---|---|---|---|---|---|---|---|---|
2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
吸烟情况 | 0.043 | 0.979 | 0.001 | 0.999 | ||||
从不吸烟 | 12 177(80.36) | 12 304(81.19) | 7 145(80.84) | 7 185(81.30) | ||||
吸烟 | 2 073(13.68) | 2 000(13.20) | 1 173(13.27) | 1 159(13.11) | ||||
已戒烟 | 904(5.96) | 850(5.61) | 520(5.88) | 494(5.59) | ||||
饮酒情况 | 0.084 | 0.994 | 0.072 | 0.995 | ||||
从不 | 13 224(87.26) | 13 441(88.70) | 7 767(87.88) | 7 824(88.53) | ||||
经常 | 1 223(8.07) | 1 021(6.74) | 687(7.77) | 603(6.82) | ||||
每天 | 418(2.76) | 456(3.01) | 255(2.89) | 284(3.21) | ||||
偶尔 | 289(1.91) | 236(1.56) | 129(1.46) | 127(1.44) | ||||
运动情况 | 10.026 | 0.018 | 1.076 | 0.783 | ||||
每天 | 6 233(41.13) | 9 435(62.26) | 3 659(41.40) | 4 196(47.48) | ||||
不锻炼 | 4 639(30.61) | 2 379(15.70) | 2 681(30.33) | 2 125(24.04) | ||||
每周≥3次 | 2 534(16.72) | 1 973(13.02) | 1 432(16.20) | 1 425(16.21) | ||||
偶尔 | 1 748(11.53) | 1 367(9.02) | 1 066(12.06) | 1 092(12.36) | ||||
服药依从性 | 8.962 | 0.011 | 1.151 | 0.562 | ||||
规律 | 10 190(67.24) | 12 708(83.86) | 5 892(66.67) | 6 438(72.84) | ||||
间断 | 2 578(17.01) | 1 670(11.02) | 1 436(16.25) | 1 350(15.27) | ||||
不服药 | 2 386(15.75) | 776(5.12) | 1 510(17.09) | 1 050(11.88) |
Table 5 Lifestyle and medication adherence between signed and unsigned groups
项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
---|---|---|---|---|---|---|---|---|
2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
吸烟情况 | 0.043 | 0.979 | 0.001 | 0.999 | ||||
从不吸烟 | 12 177(80.36) | 12 304(81.19) | 7 145(80.84) | 7 185(81.30) | ||||
吸烟 | 2 073(13.68) | 2 000(13.20) | 1 173(13.27) | 1 159(13.11) | ||||
已戒烟 | 904(5.96) | 850(5.61) | 520(5.88) | 494(5.59) | ||||
饮酒情况 | 0.084 | 0.994 | 0.072 | 0.995 | ||||
从不 | 13 224(87.26) | 13 441(88.70) | 7 767(87.88) | 7 824(88.53) | ||||
经常 | 1 223(8.07) | 1 021(6.74) | 687(7.77) | 603(6.82) | ||||
每天 | 418(2.76) | 456(3.01) | 255(2.89) | 284(3.21) | ||||
偶尔 | 289(1.91) | 236(1.56) | 129(1.46) | 127(1.44) | ||||
运动情况 | 10.026 | 0.018 | 1.076 | 0.783 | ||||
每天 | 6 233(41.13) | 9 435(62.26) | 3 659(41.40) | 4 196(47.48) | ||||
不锻炼 | 4 639(30.61) | 2 379(15.70) | 2 681(30.33) | 2 125(24.04) | ||||
每周≥3次 | 2 534(16.72) | 1 973(13.02) | 1 432(16.20) | 1 425(16.21) | ||||
偶尔 | 1 748(11.53) | 1 367(9.02) | 1 066(12.06) | 1 092(12.36) | ||||
服药依从性 | 8.962 | 0.011 | 1.151 | 0.562 | ||||
规律 | 10 190(67.24) | 12 708(83.86) | 5 892(66.67) | 6 438(72.84) | ||||
间断 | 2 578(17.01) | 1 670(11.02) | 1 436(16.25) | 1 350(15.27) | ||||
不服药 | 2 386(15.75) | 776(5.12) | 1 510(17.09) | 1 050(11.88) |
自变量 | b | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
签约家庭医生(以否为参照) | |||||
是 | 0.486 | 0.029 | 288.669 | <0.001 | 1.625(1.536~1.719) |
性别(以男为参照) | |||||
女 | 0.012 | 0.028 | 0.182 | 0.670 | 1.012(0.957~1.070) |
年龄(以65~69岁为参照) | 23.450 | <0.001 | |||
70~74岁 | -0.359 | 0.132 | 7.400 | 0.007 | 0.699(0.540~0.905) |
75~79岁 | -0.252 | 0.132 | 3.613 | 0.057 | 0.778(0.600~1.008) |
80~84岁 | -0.267 | 0.134 | 3.984 | 0.046 | 0.766(0.590~0.995) |
85~89岁 | -0.260 | 0.137 | 3.612 | 0.057 | 0.771(0.590~1.008) |
≥90岁 | -0.122 | 0.145 | 0.702 | 0.402 | 0.885(0.666~1.177) |
婚姻状况(以已婚为参照) | |||||
未婚/丧偶/离异 | -0.070 | 0.044 | 2.518 | 0.113 | 0.932(0.854~1.017) |
BMI(以<18.5 kg/m2为参照) | 2.975 | 0.395 | |||
18.5~<24.0 kg/m2 | -0.017 | 0.101 | 2.842 | 0.092 | 0.844(0.693~1.028) |
24.0~<28.0 kg/m2 | -0.032 | 0.049 | 0.434 | 0.510 | 0.968(0.880~1.066) |
≥28.0 kg/m2 | -0.040 | 0.050 | 0.630 | 0.427 | 0.961(0.871~1.060) |
中心性肥胖(以否为参照) | |||||
是 | -0.137 | 0.033 | 17.644 | <0.001 | 0.872(0.818~0.930) |
空腹血糖偏高(以否为参照) | |||||
是 | -0.249 | 0.030 | 68.491 | <0.001 | 0.780(0.735~0.827) |
血脂异常(以否为参照) | |||||
是 | -0.034 | 0.032 | 1.111 | 0.292 | 0.967(0.908~1.029) |
肝功异常(以否为参照) | |||||
是 | -0.004 | 0.036 | 0.014 | 0.906 | 0.996(0.928~1.069) |
肾功异常(以否为参照) | |||||
是 | 0.061 | 0.028 | 4.829 | 0.028 | 1.063(1.007~1.123) |
血常规异常(以否为参照) | |||||
是 | 0.006 | 0.041 | 0.019 | 0.890 | 1.006(0.927~1.091) |
尿常规异常(以否为参照) | |||||
是 | -0.011 | 0.028 | 0.144 | 0.705 | 0.989(0.936~1.046) |
心电图检查异常(以否为参照) | |||||
是 | -0.006 | 0.028 | 0.053 | 0.818 | 0.994(0.941~1.046) |
B超检查异常(以否为参照) | |||||
是 | -0.025 | 0.028 | 0.786 | 0.375 | 0.976(0.924~1.030) |
吸烟情况(以从不吸烟/已戒烟为参照) | |||||
吸烟 | 0.020 | 0.043 | 0.207 | 0.649 | 1.020(0.937~1.110) |
饮酒情况(以从不饮酒为参照) | |||||
偶尔/经常/每天 | 0.027 | 0.046 | 0.342 | 0.559 | 1.027(0.939~1.125) |
运动锻炼(以不锻炼为参照) | 3.464 | 0.325 | |||
偶尔 | 0.036 | 0.037 | 0.969 | 0.325 | 1.037(0.965~1.115) |
每周≥1次 | 0.031 | 0.047 | 0.447 | 0.504 | 1.032(0.942~1.130) |
每天 | 0.071 | 0.041 | 3.036 | 0.081 | 1.074(0.991~1.164) |
服药依从性(以不服药为参照) | 2.117 | 0.347 | |||
间断 | 0.010 | 0.042 | 0.054 | 0.817 | 1.010(0.931~1.096) |
规律 | 0.076 | 0.052 | 2.114 | 0.146 | 1.079(0.974~1.196) |
常量 | 0.819 | 0.148 | 30.777 | <0.001 | 2.268 |
Table 6 Multivariate Logistic regression analysis of the impact of family doctor contracted services on blood pressure control in elderly patients with hypertension
自变量 | b | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
签约家庭医生(以否为参照) | |||||
是 | 0.486 | 0.029 | 288.669 | <0.001 | 1.625(1.536~1.719) |
性别(以男为参照) | |||||
女 | 0.012 | 0.028 | 0.182 | 0.670 | 1.012(0.957~1.070) |
年龄(以65~69岁为参照) | 23.450 | <0.001 | |||
70~74岁 | -0.359 | 0.132 | 7.400 | 0.007 | 0.699(0.540~0.905) |
75~79岁 | -0.252 | 0.132 | 3.613 | 0.057 | 0.778(0.600~1.008) |
80~84岁 | -0.267 | 0.134 | 3.984 | 0.046 | 0.766(0.590~0.995) |
85~89岁 | -0.260 | 0.137 | 3.612 | 0.057 | 0.771(0.590~1.008) |
≥90岁 | -0.122 | 0.145 | 0.702 | 0.402 | 0.885(0.666~1.177) |
婚姻状况(以已婚为参照) | |||||
未婚/丧偶/离异 | -0.070 | 0.044 | 2.518 | 0.113 | 0.932(0.854~1.017) |
BMI(以<18.5 kg/m2为参照) | 2.975 | 0.395 | |||
18.5~<24.0 kg/m2 | -0.017 | 0.101 | 2.842 | 0.092 | 0.844(0.693~1.028) |
24.0~<28.0 kg/m2 | -0.032 | 0.049 | 0.434 | 0.510 | 0.968(0.880~1.066) |
≥28.0 kg/m2 | -0.040 | 0.050 | 0.630 | 0.427 | 0.961(0.871~1.060) |
中心性肥胖(以否为参照) | |||||
是 | -0.137 | 0.033 | 17.644 | <0.001 | 0.872(0.818~0.930) |
空腹血糖偏高(以否为参照) | |||||
是 | -0.249 | 0.030 | 68.491 | <0.001 | 0.780(0.735~0.827) |
血脂异常(以否为参照) | |||||
是 | -0.034 | 0.032 | 1.111 | 0.292 | 0.967(0.908~1.029) |
肝功异常(以否为参照) | |||||
是 | -0.004 | 0.036 | 0.014 | 0.906 | 0.996(0.928~1.069) |
肾功异常(以否为参照) | |||||
是 | 0.061 | 0.028 | 4.829 | 0.028 | 1.063(1.007~1.123) |
血常规异常(以否为参照) | |||||
是 | 0.006 | 0.041 | 0.019 | 0.890 | 1.006(0.927~1.091) |
尿常规异常(以否为参照) | |||||
是 | -0.011 | 0.028 | 0.144 | 0.705 | 0.989(0.936~1.046) |
心电图检查异常(以否为参照) | |||||
是 | -0.006 | 0.028 | 0.053 | 0.818 | 0.994(0.941~1.046) |
B超检查异常(以否为参照) | |||||
是 | -0.025 | 0.028 | 0.786 | 0.375 | 0.976(0.924~1.030) |
吸烟情况(以从不吸烟/已戒烟为参照) | |||||
吸烟 | 0.020 | 0.043 | 0.207 | 0.649 | 1.020(0.937~1.110) |
饮酒情况(以从不饮酒为参照) | |||||
偶尔/经常/每天 | 0.027 | 0.046 | 0.342 | 0.559 | 1.027(0.939~1.125) |
运动锻炼(以不锻炼为参照) | 3.464 | 0.325 | |||
偶尔 | 0.036 | 0.037 | 0.969 | 0.325 | 1.037(0.965~1.115) |
每周≥1次 | 0.031 | 0.047 | 0.447 | 0.504 | 1.032(0.942~1.130) |
每天 | 0.071 | 0.041 | 3.036 | 0.081 | 1.074(0.991~1.164) |
服药依从性(以不服药为参照) | 2.117 | 0.347 | |||
间断 | 0.010 | 0.042 | 0.054 | 0.817 | 1.010(0.931~1.096) |
规律 | 0.076 | 0.052 | 2.114 | 0.146 | 1.079(0.974~1.196) |
常量 | 0.819 | 0.148 | 30.777 | <0.001 | 2.268 |
[1] |
朱平. 老年人高血压的特点及诊疗进展[J]. 中华老年心脑血管病杂志,2021,23(8):785-787.
|
[2] |
范雷,梁森,戚敏杰,等. 河南省监测点高血压和糖尿病患者经济负担调查[J]. 中国慢性病预防与控制,2021,29(8):635-638. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.08.018.
|
[3] |
国家基本公共卫生服务项目基层高血压管理办公室、基层高血压管理专家委员会. 国家基层高血压防治管理指南[J]. 中国循环杂志,2017,32(11):1041-1048.
|
[4] |
王显君,唐智友,杨文梅,等. 基层医疗卫生机构医防"五融合"健康管理服务模式研究[J]. 中国全科医学,2020,23(31):3924-3929. DOI:10.12114/j.issn.1007-9572.2020.00.454.
|
[5] |
刘远立. 健康中国建设研究报告2023[M]. 北京:社会科学文献出版社,2023.
|
[6] |
国家卫生计生委关于印发《国家基本公共卫生服务规范(第三版)》的通知[A/OL]. (2017-02-28)[2024-10-01].
|
[7] |
李惠梅,常峪文. 体检报告解读与健康指导[M]. 北京:中国医药科技出版社,2018.
|
[8] |
陈友兰,吴阿华,娄群,等. 2022年厦门市≥65岁老年人健康体检结果分析[J]. 中国初级卫生保健,2023,37(12):13-17.
|
[9] |
宋建玲,饶志伟,韩魁,等. 家庭医生-专家"双签约"模式在社区老年慢病患者管理中的应用[J]. 老年医学与保健,2021,27(6):1319-1322.
|
[10] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545.
|
[11] |
王琦,杜文雯,宋晓昀,等. 中国成人体质指数轨迹与高血压及血压水平关系[J]. 卫生研究,2023,52(3):354-361.
|
[12] |
梦宇,连隽,廖子锐,等. 国家基本公共卫生服务老年人健康体检的异常检出率分析[J]. 中国全科医学,2023,26(22):2756-2762. DOI:10.12114/j.issn.1007-9572.2022.0831.
|
[13] |
胡承伟,吴玉苗,华志佳,等. 上海市长征镇社区空巢高血压老人血压控制情况及影响因素分析[J]. 中国全科医学,2020,23(s2):53-56.
|
[14] |
欧阳斌发,赵丹,朱利清,等. 社区高血压健康管理患者药物治疗效果分析[J]. 华南预防医学,2022,48(7):803-807.
|
[15] |
宋建玲,饶志伟,韩魁,等. 家庭医生-专家"双签约"模式在社区老年慢病患者管理中的应用[J]. 老年医学与保健,2021,27(6):1319-1322.
|
[16] |
高宇,李迈. 健康管理新模式对北京天桥社区居家老人慢性病管理的效果分析[J]. 中国社区医师,2022,38(7):140-142.
|
[17] |
王爽. 河北省沧州市沧县老年高血压患者健康管理效果及影响因素研究[D]. 北京:中国医学科学院,2023.
|
[1] | WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan. Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension [J]. Chinese General Practice, 2025, 28(24): 2972-2978. |
[2] | HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971. |
[3] | FU Rong, SHI Lei, HE Feiying. Comorbidity of Diabetes and Depression in Middle-aged and Elderly People: the Impact of Sleep, Exercise, and Social Activities [J]. Chinese General Practice, 2025, 28(20): 2491-2500. |
[4] | GUO Yi, HAN Xuanye, LIU Zhaojun, JIANG Yaoyao, FU Yang, SHI Lei, ZHAO Shihong. Construction of a Medical Transition Intervention Model for Multiple Chronic Diseases in Children Based on the E-Coach Management Model [J]. Chinese General Practice, 2025, 28(20): 2530-2537. |
[5] | FANG Yingying, LIN Weiquan, SUN Minying, LI Yaohui, LIU Lan, YANG Yunou, CHEN Jiamin, LUO Liying, SHI Lei, LIU Hui. Influence of Screen Time on Sleep Quality among Patients with Multimorbidity Aged 35 and Above [J]. Chinese General Practice, 2025, 28(20): 2501-2507. |
[6] | LIU Hongya, YU Dehua. Construction and Practice of Clinical Diagnosis and Treatment Technology Combining General Practice and Specialist in Shanghai Community [J]. Chinese General Practice, 2025, 28(19): 2390-2397. |
[7] | ZHOU Fang, DONG Yuan, WU Xiankui, JI Ying. An Evaluation of Basic Public Health Services Quality for Floating Population in China [J]. Chinese General Practice, 2025, 28(19): 2363-2369. |
[8] | HAO Aihua, ZENG Ziying, JIN Aiqiong, TANG Lingling, ZHENG Zique, MA Jingtai, ZHAO Jianguo, ZENG Weilin, XIAO Jianpeng, NIE Hui, YANG Ying. Analysis of Factors Influencing Avoidable Hospitalization for Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(19): 2370-2375. |
[9] | WANG Zhijun, ZHANG Shibo, LIU Jie, LI Dongqi, ZHENG Meijia, ZHOU Jianzhi. Correlation Analysis between TyG-BMI Index and Nocturnal Hypertension in Patients with Hypertension [J]. Chinese General Practice, 2025, 28(18): 2212-2221. |
[10] | ZHANG Zhidong, JIN Hua, HU Jihong, JIANG Lu, WANG Li, LONG Kaichong, ZHANG Ronghua. Analysis and Prediction of the Incidence and Mortality Trends of Hypertensive Nephropathy in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(18): 2262-2269. |
[11] | HE Yan, CUI Saixian, HU Yang, NI Qing, GAN Lulu, LIU Qian, DAI Anni, LIU Shijie, YANG Li. Influencing Factors on Urinary Sodium Excretion in Patients with Obstructive Sleep Apnea-Associated Hypertension [J]. Chinese General Practice, 2025, 28(18): 2222-2227. |
[12] | LYU Lulu, ZHU Wanjie, XIAO Mingyang, LI Yike, ZHANG Juan. Correlation Analysis of the Circadian Rhythmicity of Blood Pressure with Ox-LDL/β2GPI Complex and Carotid Atherosclerosis in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(18): 2228-2233. |
[13] | MEI Jingyan, CHEN Min, ZHANG Lieqiang, PAN Yunxi, WANG Xin, ZHAO Xiaodeng, ZHAN Wei, LIU Tao, WANG Yiying. Association between Cumulative Lipid Accumulation Index and Hypertension: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2205-2211. |
[14] | WANG Biqing, ZHANG Ping, YANG Hongxia, WANG Qian, JU Chunxiao, ZHAO Junnan, MEI Jun, ZHANG Ying, XU Fengqin. Meta-analysis of Prevalence and Development Trend of Mild Cognitive Impairment in Elderly Hypertensive Patients in China [J]. Chinese General Practice, 2025, 28(17): 2186-2192. |
[15] | CHENG Zhuozhuo, ZHANG Rui, XU Haofeng, HUANG Junting, LIANG Zijing, YAN Ping. Systematic Cluster Analysis of Comorbidity Patterns in Patients with Chronic Obstructive Pulmonary Disease and the Impact on Hospitalization Costs [J]. Chinese General Practice, 2025, 28(17): 2127-2133. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||